BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Oct 30, 15:40Prev. Close
129.85
Open Price
118.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Sotac Pharmaceuticals (in Rs. Cr.) | Mar 20 | |
| 12 mths | ||
| INCOME | ||
| Revenue From Operations [Gross] | 28.60 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | |
| Revenue From Operations [Net] | 28.60 | |
| Total Operating Revenues | 28.60 | |
| Other Income | 0.16 | |
| Total Revenue | 28.76 | |
| EXPENSES | ||
| Cost Of Materials Consumed | 21.75 | |
| Purchase Of Stock-In Trade | 0.16 | |
| Operating And Direct Expenses | 1.47 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -0.49 | |
| Employee Benefit Expenses | 1.69 | |
| Finance Costs | 0.24 | |
| Depreciation And Amortisation Expenses | 1.07 | |
| Other Expenses | 1.95 | |
| Total Expenses | 27.85 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 0.91 | |
| Exceptional Items | 0.00 | |
| Profit/Loss Before Tax | 0.91 | |
| Tax Expenses-Continued Operations | ||
| Current Tax | 0.25 | |
| Less: MAT Credit Entitlement | 0.00 | |
| Deferred Tax | 0.00 | |
| Tax For Earlier Years | 0.00 | |
| Total Tax Expenses | 0.21 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 0.71 | |
| Profit/Loss From Continuing Operations | 0.71 | |
| Profit/Loss For The Period | 0.71 | |
| OTHER ADDITIONAL INFORMATION | ||
| EARNINGS PER SHARE | ||
| Basic EPS (Rs.) | 7.13 | |
| Diluted EPS (Rs.) | 7.13 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||
| Imported Raw Materials | 0.00 | |
| Indigenous Raw Materials | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||
| Imported Stores And Spares | 0.00 | |
| Indigenous Stores And Spares | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||
| Equity Share Dividend | 0.00 | |
| Tax On Dividend | 0.00 | |
| Equity Dividend Rate (%) | 0.00 |
30.10.2024
Sotac Pharma Consolidated September 2024 Net Sales at Rs 27.35 crore, up 2.52% Y-o-Y
27.08.2024
Sotac Pharma Consolidated June 2024 Net Sales at Rs 25.25 crore, up 1.13% Y-o-Y
19.08.2024
Sotac Pharma Standalone June 2024 Net Sales at Rs 13.01 crore, down 31.18% Y-o-Y
18.06.2024
Sotac Pharma Consolidated March 2024 Net Sales at Rs 26.45 crore, up 46.24% Y-o-Y
30.10.2024
Sotac Pharma Consolidated September 2024 Net Sales at Rs 27.35 crore, up 2.52% Y-o-Y
27.08.2024
Sotac Pharma Consolidated June 2024 Net Sales at Rs 25.25 crore, up 1.13% Y-o-Y
19.08.2024
Sotac Pharma Standalone June 2024 Net Sales at Rs 13.01 crore, down 31.18% Y-o-Y
18.06.2024
Sotac Pharma Consolidated March 2024 Net Sales at Rs 26.45 crore, up 46.24% Y-o-Y